Lorazepam as an Adjunct Antiemetic
Lorazepam (Ativan) is appropriate as an adjunct antiemetic but should never be used as monotherapy for chemotherapy-induced nausea and vomiting (CINV). 1
Role in Antiemetic Regimens
Lorazepam functions as a useful adjunctive agent that addresses the anxiety component of nausea and vomiting, particularly for anticipatory symptoms, but lacks direct antiemetic properties sufficient for standalone use. 1, 2
Specific Clinical Applications
Anticipatory Nausea and Vomiting
- Lorazepam 1 mg PO at bedtime the night before chemotherapy and 1 mg the morning of chemotherapy is the recommended regimen for anticipatory symptoms, which are anxiety-driven phenomena. 3
- Behavioral modification and biofeedback techniques should be offered as complementary interventions. 3
Adjunctive Use with Primary Antiemetics
- For highly emetogenic chemotherapy (Grade 4): Lorazepam 1 mg PO every 1–2 hours PRN can be added to the standard regimen of 5-HT₃ antagonist plus dexamethasone plus NK₁ antagonist. 3
- For moderately emetogenic chemotherapy: Lorazepam 0.5–2 mg PO/IV/sublingual every 4–6 hours PRN may be added to dexamethasone and 5-HT₃ antagonist combinations. 4, 5, 4
- For low emetogenic chemotherapy: Lorazepam 0.5–2 mg PO/IV every 4–6 hours PRN can supplement dexamethasone, metoclopramide, or prochlorperazine. 4
Dosing Recommendations
Standard Dosing
- Oral/IV/sublingual: 0.5–2 mg every 4–6 hours as needed 4, 5, 4
- Anticipatory symptoms: 1 mg PO the night before and morning of chemotherapy 3
- Breakthrough nausea: 0.5–2 mg PO every 4–6 hours 4
Critical Dosing Caveat
- Do not administer if the patient has excessive drowsiness, as this increases the risk of respiratory depression and oversedation. 3
- The FDA label specifies that IV lorazepam should not exceed 2 mg/min injection rate, with equipment to maintain a patent airway immediately available. 6
Monitoring Requirements
Respiratory Monitoring
- Equipment to maintain a patent airway must be immediately available prior to IV administration, particularly when lorazepam is combined with other CNS depressants. 6
- Monitor for additive CNS depression when used with phenothiazines (prochlorperazine), metoclopramide, or opioid analgesics. 6
Sedation Assessment
- Assess baseline sedation level before each dose. 3
- Lorazepam produces amnesia for perioperative/chemotherapy events, which may be desirable but requires patient counseling. 6, 7
- Transient enuresis while sedated has been reported and should be anticipated. 7
Drug Interactions Requiring Dose Adjustment
- Reduce lorazepam dose by 50% when coadministered with probenecid or valproate due to decreased clearance. 6
- Consider dose increase in female patients taking oral contraceptives, as these medications increase lorazepam clearance by 3.7-fold. 6
Evidence Supporting Adjunctive Use
Efficacy Data
- A randomized trial in cisplatin-treated patients demonstrated that lorazepam plus metoclopramide plus dexamethasone reduced anxiety (p=0.0001) and treatment-related restlessness (3% vs 19%, p=0.007) compared to diphenhydramine-containing regimens. 7
- In acute leukemia patients, adding oral lorazepam 1 mg/day to metoclopramide achieved complete or partial emesis control in 100% of patients versus 55% with metoclopramide alone (p<0.001). 8
- A crossover study showed that lorazepam 2.5 mg significantly shortened nausea duration (p<0.01) and was preferred by 80% of patients (p<0.003) when added to metoclopramide plus methylprednisolone. 9
Psychological Benefits
- Lorazepam reduces anxiety and improves the amnestic process, enhancing overall tolerability of chemotherapy. 9
- Patient preference strongly favors lorazepam-containing regimens (85.7–89% vs 30–83% for regimens without lorazepam). 7, 8
Common Pitfalls and How to Avoid Them
Never Use as Monotherapy
- The most critical error is prescribing lorazepam alone for CINV. It lacks sufficient antiemetic efficacy and is explicitly contraindicated as a single agent by ASCO guidelines. 1, 2
- Always combine with appropriate primary antiemetics based on emetogenic risk (5-HT₃ antagonists, NK₁ antagonists, dexamethasone). 1, 2
Avoid in Excessive Drowsiness
- Check alertness before each dose—if the patient is already excessively drowsy, skip the lorazepam dose to prevent respiratory compromise. 3
Recognize Contraindications
- Lorazepam contains benzyl alcohol and should be used cautiously in neonates and pregnant women. 6
- Neonatal sedation and withdrawal syndrome can occur with late-pregnancy use. 6
Monitor for Paradoxical Reactions
- When combined with scopolamine, lorazepam increases the incidence of hallucinations and irrational behavior. 6
- Rare but serious interactions include respiratory depression with loxapine, marked sedation with clozapine, and apnea/bradycardia with haloperidol. 6